基准编辑者介导的血液细胞干细胞基因疗法用于血液疾病
Chengpeng Zhang1, Jinchao Xu1, Yikang Wu1
1Cyrus Tang Medical Institute, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Collaborative Innovation Center of Hematology, Soochow Medical College, Soochow University, Suzhou, 215123, Jiangsu Province, China.
Stem cell reviews and reports
|April 21, 2024
概括
基组编辑器为造血干细胞 (HSC) 提供精确的基因编辑,而不会导致双链断裂. 这一进步对开发有效和持久的基于HSC的基因疗法具有重大前景.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 基因编辑 基因编辑
背景情况:
- 基于CRISPR/Cas技术的基础编辑器自2016年以来已经取得了很大的进步.
- 优化改进了基础编辑器的精度,效率和安全性.
- 基准编辑器正在被探索用于基因治疗应用.
研究的目的:
- 审查DNA数据库编辑器的发展和进展.
- 讨论基础编辑器在造血干细胞 (HSC) 基因治疗中的应用.
- 突出临床干细胞治疗的未来前景和挑战.
主要方法:
- 关于基础编辑器技术和应用的科学文献的综述.
- 对基编辑机制的分析,重点关注除氨酶和Cas变体.
- 在疾病模型和HSC中评估基准编辑器性能.
主要成果:
- 基数编辑器可以实现精确的单基替换,而不会引发双链断裂 (DSB).
- 在HSC中这种精确的编辑提供了永久性遗传缺陷纠正的潜力.
- 与CRISPR/Cas相比,基准编辑器对于基于HSC的基因治疗具有很大的潜力.
结论:
- 基础编辑器的近期进展有望加速HSC基因疗法的临床试验.
- 基准编辑器的精确和安全的编辑能力对于有效的基因治疗至关重要.
- 需要进一步的研究,以应对未来临床干细胞治疗的挑战.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Bone Marrow Sampling and Transplants
327
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
327


